IR@PKUHSC  > 北京大学第一临床医学院  > 心血管内科
学科主题临床医学
Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis
Qin, Xianhui4; Huo, Yong5,6; Langman, Craig B.7; Hou, Fanfan8; Chen, Yundai9; Matossian, Debora7; Xu, Xiping10; Wang, Xiaobin1,2,3
刊名CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2011-03-01
DOI10.2215/CJN.05310610
6期:3页:482-488
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Urology & Nephrology
研究领域[WOS]Urology & Nephrology
关键词[WOS]RANDOMIZED CONTROLLED-TRIAL ; STAGE RENAL-DISEASE ; RISK-FACTOR ; B-VITAMINS ; HOMOCYSTEINE ; MORTALITY ; EVENTS ; SUPPLEMENTATION ; PREVENTION ; STATEMENT
英文摘要

Background and objectives The efficacy of folic acid therapy to lower homocysteine (Hcy) levels in an effort to reduce cardiovascular disease (CVD) risk in patients with ESRD or advanced chronic kidney disease (ACKD; creatinine clearance, <30 ml/min) remains inconclusive. We conducted a meta-analysis of relevant randomized trials to further examine this issue.

Design, setting, participants, & measurements This meta-analysis included 3886 patients with ESRD/ACKD from seven qualified randomized trials using folic acid therapy and with CVD reported as one of the end points.

Results When pooling the seven trials, folic acid therapy reduced the risk of CVD by 15% (RR, 0.85; 95% CI, 0.76 to 0.96; P = 0.009). A greater beneficial effect was observed among those trials with a treatment duration >24 months (RR, 0.84; 95% Cl, 0.72 to 0.98; P = 0.02), a decrease in Hcy level >20% (RR, 0.83; 95% CI, 0.73 to 0.95; P = 0.007), and no or partial folic acid fortification (RR, 0.80; 95% CI, 0.65 to 0.99; P = 0.04). The beneficial effect also was seen when Hcy levels decreased >20%, even in the presence of folic acid fortification (RR, 0.85; 95% CI, 0.73 to 0.99; P = 0.04). In the corresponding comparison groups, the estimated RRs were attenuated and insignificant.

Conclusions Folic acid therapy can reduce CVD risk in patients with ESRD/ACKD by 15%. A greater beneficial effect was observed among those trials with no or partial folic acid fortification or a decrease in Hcy level >20% regardless of folic acid fortification. Clin J Am Soc Nephrol 6: 482-488, 2011. doi: 10.2215/CJN.05310610

语种英语
WOS记录号WOS:000288480100005
引用统计
被引频次:38[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/54676
专题北京大学第一临床医学院_心血管内科
作者单位1.Peking Univ, Hosp 1, Ctr Heart, Beijing 100871, Peoples R China
2.Childrens Mem Res Ctr, Chicago, IL USA
3.Anhui Med Univ, Inst Biomed, Hefei, Peoples R China
4.NW Univ Feinberg, Sch Med, Childrens Mem Hosp, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60614 USA
5.NW Univ Feinberg, Sch Med, Dept Pediat, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60614 USA
6.Peking Univ, Hosp 1, Dept Cardiol, Beijing 100871, Peoples R China
7.NW Univ Feinberg, Sch Med, Childrens Mem Hosp, Div Kidney Dis, Chicago, IL 60614 USA
8.So Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China
9.Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China
10.Univ Illinois, Chicago Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA
推荐引用方式
GB/T 7714
Qin, Xianhui,Huo, Yong,Langman, Craig B.,et al. Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis[J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,2011,6(3):482-488.
APA Qin, Xianhui.,Huo, Yong.,Langman, Craig B..,Hou, Fanfan.,Chen, Yundai.,...&Wang, Xiaobin.(2011).Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,6(3),482-488.
MLA Qin, Xianhui,et al."Folic Acid Therapy and Cardiovascular Disease in ESRD or Advanced Chronic Kidney Disease: A Meta-Analysis".CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 6.3(2011):482-488.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Qin, Xianhui]的文章
[Huo, Yong]的文章
[Langman, Craig B.]的文章
百度学术
百度学术中相似的文章
[Qin, Xianhui]的文章
[Huo, Yong]的文章
[Langman, Craig B.]的文章
必应学术
必应学术中相似的文章
[Qin, Xianhui]的文章
[Huo, Yong]的文章
[Langman, Craig B.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。